Literature DB >> 33661913

Independent predictors of acute kidney injury in patients with acute coronary syndrome after percutaneous coronary intervention.

Aisulu Zhunuspekova1, Jamilya Mansurova2, Lyudmila Karazhanova1.   

Abstract

INTRODUCTION: High residual platelet reactivity (RPR) in patients after percutaneous coronary intervention (PCI) receiving antiplatelet agents has been associated with a high risk of developing acute kidney injury (AKI). STUDY AIM: This study aimed at identification of independent prognostic predictors of AKI risk in patients with acute coronary syndrome (ACS) after PCI. STUDY DESIGN, SETTING AND PATIENTS: This was a prospective single-center clinical trial that included 155 patients (n = 119 without AKI, n = 36 with AKI, mean age 64.0±10.6 years, of whom 74.2% were males), who underwent PCI with stenting. We prospectively evaluated RPR using optical aggregometry. Development of AKI was the primary endpoint.
RESULTS: Acute renal dysfunction was observed in 36 patients (23.2%) after PCI, the risk factors of which according to univariate regression analysis were: age (p = 0.040), low diastolic blood pressure (DBP) (p = 0.001), having severe heart failure (HF) according to Killip (p<0.001), low level of hemoglobin (p = 0.026) and erythrocytes (p = 0.005), increased creatinine (p<0.001), low baseline glomerular filtration rate (GFR) (p<0.001), low left ventricular ejection fraction (LV EF) (p = 0.003), high residual platelet reactivity (RPR) (p<0.001) and platelet aggregation area under the curve (AUC) with 10 μg/mL ADP (p<0.001), as well as dose of X-ray contrast medium (XCM) (p = 0.008). As a result of multivariate regression analysis the following independent predictors of AKI were established with the inclusion of the above factors: baseline creatinine level [OR 1.033 at 95% CI from 1.017 to 1.049; p<0.001], RPR with 10 μg/mL ADP [OR 1.060 at 95% CI from 1.027 to 1.094; p = 0.001], dose of an XCM [ОR 1.005 at 95% CI from 1.001 to 1.008; р = 0.014], diastolic blood pressure (DBP) [OR 0.926 at 95% CI from 0.888 to 0.965; p<0.001].
CONCLUSION: ADP-induced high residual platelet reactivity, baseline creatinine level, X-ray contrast medium, low diastolic blood pressure were independent predictors of AKI in patients with ACS after PCI.

Entities:  

Year:  2021        PMID: 33661913      PMCID: PMC7932092          DOI: 10.1371/journal.pone.0247304

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  36 in total

1.  2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

Authors:  Stephan Windecker; Philippe Kolh; Fernando Alfonso; Jean-Philippe Collet; Jochen Cremer; Volkmar Falk; Gerasimos Filippatos; Christian Hamm; Stuart J Head; Peter Jüni; A Pieter Kappetein; Adnan Kastrati; Juhani Knuuti; Ulf Landmesser; Günther Laufer; Franz-Josef Neumann; Dimitrios J Richter; Patrick Schauerte; Miguel Sousa Uva; Giulio G Stefanini; David Paul Taggart; Lucia Torracca; Marco Valgimigli; William Wijns; Adam Witkowski
Journal:  Eur Heart J       Date:  2014-08-29       Impact factor: 29.983

2.  High on-treatment platelet reactivity as a risk factor for secondary prevention after coronary stent revascularization: A landmark analysis of the ARCTIC study.

Authors:  Gilles Montalescot; Grégoire Rangé; Johanne Silvain; Jean-Louis Bonnet; Ziad Boueri; Olivier Barthélémy; Guillaume Cayla; Loic Belle; Eric Van Belle; Thomas Cuisset; Simon Elhadad; Christophe Pouillot; Patrick Henry; Pascal Motreff; Didier Carrié; Hélène Rousseau; Pierre Aubry; Jacques Monségu; Pierre Sabouret; Stephen A O'Connor; Jérémie Abtan; Mathieu Kerneis; Christophe Saint-Etienne; Farzin Beygui; Eric Vicaut; Jean-Philippe Collet
Journal:  Circulation       Date:  2014-04-09       Impact factor: 29.690

3.  Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial.

Authors:  Dirk Sibbing; Dániel Aradi; Claudius Jacobshagen; Lisa Gross; Dietmar Trenk; Tobias Geisler; Martin Orban; Martin Hadamitzky; Béla Merkely; Róbert Gábor Kiss; András Komócsi; Csaba A Dézsi; Lesca Holdt; Stephan B Felix; Radoslaw Parma; Mariusz Klopotowski; Robert H G Schwinger; Johannes Rieber; Kurt Huber; Franz-Josef Neumann; Lukasz Koltowski; Julinda Mehilli; Zenon Huczek; Steffen Massberg
Journal:  Lancet       Date:  2017-08-28       Impact factor: 79.321

4.  Contrast-Induced Nephropathy in STEMI Patients With and Without Chronic Kidney Disease.

Authors:  Tarun Jain; Sunay Shah; Jainil Shah; Gordon Jacobsen; Akshay Khandelwal
Journal:  Crit Pathw Cardiol       Date:  2018-03

Review 5.  GFR estimation: from physiology to public health.

Authors:  Andrew S Levey; Lesley A Inker; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2014-01-28       Impact factor: 8.860

6.  A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) study.

Authors:  Dietmar Trenk; Gregg W Stone; Meinrad Gawaz; Adnan Kastrati; Dominick J Angiolillo; Ulrike Müller; Gert Richardt; Joseph A Jakubowski; Franz-Josef Neumann
Journal:  J Am Coll Cardiol       Date:  2012-04-18       Impact factor: 24.094

7.  Acute kidney injury in acute coronary syndromes - An important multifactorial consequence.

Authors:  David Neves; Adriana Belo; Ana Filipa Damásio; João Carvalho; Ana Rita Santos; Bruno Piçarra; José Aguiar
Journal:  Rev Port Cardiol       Date:  2016-06-30       Impact factor: 1.374

8.  Elevated admission serum creatinine predicts poor myocardial blood flow and one-year mortality in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.

Authors:  Lin Zhao; Lei Wang; Yuchen Zhang
Journal:  J Invasive Cardiol       Date:  2009-10       Impact factor: 2.022

9.  Contribution of platelets indices in the development of contrast-induced nephropathy.

Authors:  Irfan Sahin; Ahmet Karabulut; Ilhan Iker Avci; Ertugrul Okuyan; Halil I Biter; Suleyman S Yildiz; Mehmet M Can; Baris Gungor; Mustafa Dinckal; Victor Serebruany
Journal:  Blood Coagul Fibrinolysis       Date:  2015-04       Impact factor: 1.276

10.  Could platelet-to-lymphocyte ratio be a predictor for contrast-induced nephropathy in patients with acute coronary syndrome?: A systematic review and meta-analysis.

Authors:  Jie Jiang; Hong-Yan Ji; Wei-Ming Xie; Lu-Sen Ran; Yu-Si Chen; Cun-Tai Zhang; Xiao-Qing Quan
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

View more
  2 in total

1.  Association between Biomarkers of Oxidative Stress and Inflammation with Cardiac Necrosis and Heart Failure in Non-ST Segment Elevation Myocardial Infarction Patients and Various Degrees of Kidney Function.

Authors:  Stefanos Roumeliotis; Andrej Veljkovic; Panagiotis I Georgianos; Gordana Lazarevic; Zoran Perisic; Jovan Hadzi-Djokic; Vassilios Liakopoulos; Gordana Kocic
Journal:  Oxid Med Cell Longev       Date:  2021-11-01       Impact factor: 6.543

2.  Frequency and Predictors of Acute Kidney Injury in Patients With Acute Coronary Syndrome in a Tertiary Care Hospital: A Retrospective Study.

Authors:  Hemanth Kumar; Daniyal Jilanee; Shivani M Mehta; Amna Gul; Syed Muhammad Huzaifa Shah; Sumaira Saleem; Maria Binte Sarfraz; Syed U Ashraf; Sher Wali
Journal:  Cureus       Date:  2022-02-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.